Dear Sir
This is a very opportune time for you as an investor. Vein illumination is a $275M business just in the USA, and it is a $2 billion dollar business worldwide. We have a legitimate chance to gain the majority of that business.
· The leading selling vein illumination device manufacturer used more than $13M in VC funding to get to the same point where we are today.
a. We accomplished the same task with less than $800,000 from the Founder and small investors.
· The leading selling vein illumination device manufacturer then used another $10M in VC funding to launch sales.
a. We will be very successful with one-tenth of that.
Near Infrared Imaging’s Vein-Eye illuminates veins for easier vein punctures. It began shipping to distributors in October, 2014, and NII already has distributors in twenty-nine (29) countries. NII has incoming revenue and profits to justify an investment based solely upon the existing Vein-Eye product line, as described in the attached investor PDF.
· Puncturing a vein is a difficult task on any occasion.
· But, puncturing a vein is extremely difficult when the patient is dark in color, sick, very young, very old, or the veins have collapsed due to dehydration.
· And, if the patient has Ebola, AIDS, SARS, Measles, Chicken Pox or Tuberculosis, the procedure can be dangerous to both the patient and healthcare practitioner.
Your investment funds will be used to quicken the successful launch of the existing Vein-Eye product. With your funds, we will hire senior-level sales managers, hire a Director of Technology, purchase inventory at a greater quantity in order to secure more discounts, and increase our marketing and sales efforts.
In addition, your funds will be used to develop the new Vein-Eye CARRY, which will soon become the gold standard in vein illumination. The CARRY will eliminate much of the competition due to its performance and price points. The CARRY is a response to the demands from end users for a product similar to the GoPro camera: more robust, more powerful, more features, smaller, more portable, and less expensive.
And, we will develop other products with the profits generated by the Vein-Eye products. Please review the attached PDF – Near Infrared imaging Overview – to understand the quality of our patented technologies and our potential.
Non-contact vein-recognition biometrics is a multi-billion $$$ business worldwide. Iris scanning can be compromised due to contact lenses, blood in the eye, alcohol consumption, drug consumption, smoking and changes in the biology of the individual. Fingerprint identification requires contact.
NII’s “multi-modality” imaging scheme for non-contact vein recognition biometrics is second to none. The NII-BIO will be able to be implemented on night-vision goggles, mobile devices, cell phones, Tablets, PCs and other smart devices. The time it takes for someone to show their palm to the NII reader, and receive positive confirmation, is about one-half of a second.
Since NII is owned in part by the Dept. of Energy and the NSA, we will have immediate access to the FBI, CIA, Dept. of Defense military and civilian markets, Homeland Security and the TSA at airports. The time for our solution is now.
In the meantime,please don't hesitate to reach out if you have any question.
We look forward to wonder relationship together and success for all concerned.
The best regards;
Ahmed elseidy
Business Development GCC Region
Near Infrared Imaging , Inc
Wrentham MA 02093 , USA
T: +966-590-670071
elseidy@nearinfraredimaging.com
www.nearinfraredimaging.com
heba_pharma2000@yahoo.com
Skype: ahmedelseidy